Neurological soft signs in patients with schizophrenia: current knowledge and future perspectives in the post-genomics era

References

• Tandon R, Nasrallah HA, Keshavan MS. Schizophrenia, ‘just the facts’ 4. Clinical features and conceptualization. Schizophr Res. 2009; 110: 1–23.
   PubMed Web of Science ®Google Scholar
• van Os J, Kapur S. Schizophrenia. Lancet. 2009; 374: 635–45.
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull. 2009; 35: 528–48.
   PubMed Web of Science ®Google Scholar
• Rapoport JL, Addington AM, Frangou S, Psych MRC. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005; 10: 434–49.
   PubMed Web of Science ®Google Scholar
• Gratten J, Wray NR, Keller MC, Visscher PM. Large-scale genomics unveils the genetic architecture of psychiatric disorders. Nat Neurosci. 2014; 17: 782–90.
   PubMed Web of Science ®Google Scholar
• Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511 : 421–7.
   PubMed Web of Science ®Google Scholar
• Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry. 2002; 159: 1080–92.
   PubMed Web of Science ®Google Scholar
• Keshavan M, Gilbert A, Diwadkar V. Lieberman JA, Stroup TS, Perkins DO. Neurodevelopmental theories. The American Psychiatric Publishing textbook of schizophrenia. 2006; Washington, DC: American Psychiatric Publishing Inc. 69–84.
   Google Scholar
• Brown AS. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull. 2006; 32: 200–2.
   PubMed Web of Science ®Google Scholar
• Brown AS, Derkits EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry. 2010; 167: 261–80.
   PubMed Web of Science ®Google Scholar
• Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, etal. Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry. 2002; 59: 449–56.
   PubMed Web of Science ®Google Scholar
• Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull. 1994; 20: 441–51.
   PubMed Web of Science ®Google Scholar
• Jones P, Rodgers B, Murray R, Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 1994; 344: 1398–402.
   PubMed Web of Science ®Google Scholar
• Murray GK, Jones PB, Moilanen K, Veijola J, Miettunen J, Cannon TD, etal. Infant motor development and adult cognitive functions in schizophrenia. Schizophr Res. 2006; 81: 65–74.
   PubMed Web of Science ®Google Scholar
• Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ. 1994; 309: 699–703.
   PubMed Web of Science ®Google Scholar
• Olin SC, Mednick SA. Risk factors of psychosis: identifying vulnerable populations premorbidly. Schizophr Bull. 1996; 22: 223–40.
   PubMed Web of Science ®Google Scholar
• Davidson M, Reichenberg A, Rabinowitz J, Weiser M, Kaplan Z, Mark M. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am J Psychiatry. 1999; 156: 1328–35.
   PubMed Web of Science ®Google Scholar
• Sørensen HJ, Mortensen EL, Parnas J, Mednick SA. Premorbid neurocognitive functioning in schizophrenia spectrum disorder. Schizophr Bull. 2006; 32: 578–83.
   PubMed Web of Science ®Google Scholar
• Meier MH, Caspi A, Reichenberg A, Keefe RSE, Fisher HL, Harrington H, etal. Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study. Am J Psychiatry. 2014; 171: 91–101.
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Diwadkar VA, Montrose DM, Rajarethinam R, Sweeney JA. Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr Res. 2005; 79: 45–57.
   PubMed Web of Science ®Google Scholar
• Douaud G, Mackay C, Andersson J, James S, Quested D, Ray MK, etal. Schizophrenia delays and alters maturation of the brain in adolescence. Brain J Neurol. 2009; 132: 2437–48.
   Google Scholar
• Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, etal. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophr Bull. 2015; 41: 574–83.
   PubMed Web of Science ®Google Scholar
• Compton MT, Chan RCK, Walker EF, Buckley PF. Minor physical anomalies: potentially informative vestiges of fetal developmental disruptions in schizophrenia. Int J Dev Neurosci. 2011; 29: 245–50.
   Web of Science ®Google Scholar
• Lloyd T, Dazzan P, Dean K, Park SBG, Fearon P, Doody GA, etal. Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity. Psychol Med. 2008; 38: 71–7.
   PubMed Web of Science ®Google Scholar
• Golembo-Smith S, Walder DJ, Daly MP, Mittal VA, Kline E, Reeves G, etal. The presentation of dermatoglyphic abnormalities in schizophrenia: a meta-analytic review. Schizophr Res. 2012; 142: 1–11.
   PubMed Web of Science ®Google Scholar
• Fatjó-Vilas M, Gourion D, Campanera S, Mouaffak F, Levy-Rueff M, Navarro ME, etal. New evidences of gene and environment interactions affecting prenatal neurodevelopment in schizophrenia-spectrum disorders: a family dermatoglyphic study. Schizophr Res. 2008; 103: 209–17.
   PubMed Web of Science ®Google Scholar
• Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry. 1988; 145: 11–18.
   PubMed Web of Science ®Google Scholar
• Buchanan RW, Heinrichs DW. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 1989; 27: 335–50.
   PubMed Web of Science ®Google Scholar
• Chen EY, Shapleske J, Luque R, McKenna PJ, Hodges JR, Calloway SP, etal. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res. 1995; 56: 183–204.
   PubMed Web of Science ®Google Scholar
• Bombin I. Significance and meaning of neurological signs in schizophrenia: two decades later. Schizophr Bull. 2005; 31: 962–77.
   PubMed Web of Science ®Google Scholar
• Egan MF, Hyde TM, Bonomo JB, Mattay VS, Bigelow LB, Goldberg TE, etal. Relative risk of neurological signs in siblings of patients with schizophrenia. Am J Psychiatry. 2001; 158: 1827–34.
   PubMed Web of Science ®Google Scholar
• Krebs MO, Gut-Fayand A, Bourdel M, Dischamp J, Olié J. Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophr Res. 2000; 45: 245–60.
   PubMed Web of Science ®Google Scholar
• Chan RCK, Wang Y, Wang L, Chen EYH, Manschreck TC, Li Z, etal. Neurological soft signs and their relationships to neurocognitive functions: a re-visit with the structural equation modeling design. PLoS One. 2009; 4: e8469.
   Web of Science ®Google Scholar
• Mouchet-Mages S, Rodrigo S, Cachia A, Mouaffak F, Olie JP, Meder JF, etal. Correlations of cerebello-thalamo-prefrontal structure and neurological soft signs in patients with first-episode psychosis. Acta Psychiatr Scand. 2011; 123: 451–8.
   Web of Science ®Google Scholar
• Gay O, Plaze M, Oppenheim C, Mouchet-Mages S, Gaillard R, Olié JP, etal. Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull. 2013; 39: 820–9.
   Web of Science ®Google Scholar
• Janssen J, Diaz-Caneja A, Reig S, Bombín I, Mayoral M, Parellada M, etal. Brain morphology and neurological soft signs in adolescents with first-episode psychosis. Br J Psychiatry. 2009; 195: 227–33.
   PubMed Web of Science ®Google Scholar
• Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, etal. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain J Neurol. 2004; 127: 143–53.
   Google Scholar
• Hirjak D, Wolf RC, Stieltjes B, Hauser T, Seidl U, Thiemann U, etal. Neurological soft signs and brainstem morphology in first-episode schizophrenia. Neuropsychobiology. 2013; 68: 91–9.
   PubMed Web of Science ®Google Scholar
• Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, etal. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. Am J Psychiatry. 2003; 160: 1298–304.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Li Z, Huang J, Yan C, Dazzan P, Pantelis C, etal. Neurological soft signs are not ‘soft’ in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr Bull. 2014; 40: 626–41.
   PubMed Web of Science ®Google Scholar
• Chan RCK, Gottesman II. Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?. Neurosci Biobehav Rev. 2008; 32: 957–71.
   PubMed Web of Science ®Google Scholar
• Chan RCK, Xu T, Heinrichs RW, Yu Y, Wang Y. Neurological soft signs in schizophrenia: a meta-analysis. Schizophr Bull. 2010; 36: 1089–104.
   PubMed Web of Science ®Google Scholar
• Varambally S, Venkatasubramanian G, Gangadhar BN. Neurological soft signs in schizophrenia – the past, the present and the future. Indian J Psychiatry. 2012; 54: 73–80.
   PubMedGoogle Scholar
• Gupta S, Andreasen NC, Arndt S, Flaum M, Schultz SK, Hubbard WC, etal. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. Am J Psychiatry. 1995; 152: 191–6.
   PubMed Web of Science ®Google Scholar
• Scheffer RE. Abnormal neurological signs at the onset of psychosis. Schizophr Res. 2004; 70: 19–26.
   PubMed Web of Science ®Google Scholar
• Flashman LA, Flaum M, Gupta S, Andreasen NC. Soft signs and neuropsychological performance in schizophrenia. Am J Psychiatry. 1996; 153: 526–32.
   PubMed Web of Science ®Google Scholar
• Buchanan RW, Kirkpatrick B, Heinrichs DW, Carpenter WT. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 1990; 147: 290–4.
   PubMed Web of Science ®Google Scholar
• Mohr F, Hubmann W, Cohen R, Bender W, Haslacher C, Hönicke S, etal. Neurological soft signs in schizophrenia: assessment and correlates. Eur Arch Psychiatry Clin Neurosci. 1996; 246: 240–8.
   PubMed Web of Science ®Google Scholar
• Arango C, Kirkpatrick B, Buchanan RW. Neurological signs and the heterogeneity of schizophrenia. Am J Psychiatry. 2000; 157: 560–5.
   PubMed Web of Science ®Google Scholar
• Tiryaki A, Yazici MK, Anil AE, Kabakçi E, Karaağaoğlu E, Göğüş A. Reexamination of the characteristics of the deficit schizophrenia patients. Eur Arch Psychiatry Clin Neurosci. 2003; 253 : 221–7.
   PubMed Web of Science ®Google Scholar
• Mittal VA, Dean DJ, Bernard JA, Orr JM, Pelletier-Baldelli A, Carol EE, etal. Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective. Schizophr Bull. 2014; 40: 1204–15.
   Web of Science ®Google Scholar
• Bartkó G, Zádor G, Horváth S, Herczeg I. Neurological soft signs in chronic schizophrenic patients: clinical correlates. Biol Psychiatry. 1988; 24: 458–60.
   PubMed Web of Science ®Google Scholar
• Browne S, Clarke M, Gervin M, Lane A, Waddington JL, Larkin C, etal. Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med. 2000; 30: 1433–41.
   PubMed Web of Science ®Google Scholar
• Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry. 2006; 67(Suppl 9): 3–8; discussion 36–42.
   Google Scholar
• Keefe RSE. The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness. J Clin Psychiatry. 2014; 75(Suppl 2): 8–13.
   PubMed Web of Science ®Google Scholar
• Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow TJ. Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry. 1990; 157: 182–9.
   PubMed Web of Science ®Google Scholar
• Wong AH, Voruganti LN, Heslegrave RJ, Awad AG. Neurocognitive deficits and neurological signs in schizophrenia. Schizophr Res. 1997; 23: 139–46.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Bucci P, Mucci A, D'Amato AC, Conforti R, Maj M. Simple schizophrenia’: a controlled MRI and clinical/neuropsychological study. Psychiatry Res. 1999; 91: 175–84.
   Web of Science ®Google Scholar
• Peralta V, de Jalón EG, Campos MS, Basterra V, Sanchez-Torres A, Cuesta MJ. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders. Psychol Med. 2011; 41: 1279–89.
   PubMed Web of Science ®Google Scholar
• Walker E, Lewine RJ. Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am J Psychiatry. 1990; 147: 1052–6.
   PubMed Web of Science ®Google Scholar
• Cannon TD, van Erp TGM, Bearden CE, Loewy R, Thompson P, Toga AW, etal. Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull. 2003; 29: 653–69.
   PubMed Web of Science ®Google Scholar
• Thomann PA, Wüstenberg T, Santos VD, Bachmann S, Essig M, Schröder J. Neurological soft signs and brain morphology in first-episode schizophrenia. Psychol Med. 2009; 39: 371–9.
   PubMed Web of Science ®Google Scholar
• Erlenmeyer-Kimling L, Rock D, Roberts SA, Janal M, Kestenbaum C, Cornblatt B, etal. Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry. 2000; 157: 1416–22.
   PubMed Web of Science ®Google Scholar
• Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry. 1994; 151: 1231–3.
   PubMed Web of Science ®Google Scholar
• Venkatasubramanian G, Latha V, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Jayakumar PN, etal. Neurological soft signs in never-treated schizophrenia. Acta Psychiatr Scand. 2003; 108: 144–6.
   PubMed Web of Science ®Google Scholar
• Schubert EW, McNeil TF. Neurobehavioral deficits in young adult offspring with heightened risk for psychosis who developed schizophrenia-spectrum disorder. Schizophr Res. 2007; 94: 107–13.
   Web of Science ®Google Scholar
• Zabala A, Robles O, Parellada M, Moreno DM, Ruiz-Sancho A, Burdalo M, etal. Neurological soft signs in adolescents with first episode psychosis. Eur Psychiatry. 2006; 21: 283–7.
   PubMed Web of Science ®Google Scholar
• Mayoral M, Bombín I, Castro-Fornieles J, González-Pinto A, Otero S, Parellada M, etal. Longitudinal study of neurological soft signs in first-episode early-onset psychosis. J Child Psychol Psychiatry. 2012; 53: 323–31.
   PubMed Web of Science ®Google Scholar
• Mayoral M, Bombín I, Zabala A, Robles O, Moreno D, Parellada M, etal. Neurological soft signs in adolescents with first episode psychosis: two-year followup. Psychiatry Res. 2008; 161: 344–8.
   PubMed Web of Science ®Google Scholar
• Bachmann S, Degen C, Geider FJ, Schröder J. Neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis. Front Psychiatry. 2014; 5: 185.
   PubMed Web of Science ®Google Scholar
• Chen EY, Hui CL, Chan RC, Dunn EL, Miao MY, Yeung WS, etal. A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophr Res. 2005; 75: 45–54.
   PubMed Web of Science ®Google Scholar
• Mrad A, Mechri A, Slama H, Mokni S, Letaief M, Gha L. Correlations between obstetric complications and neurological soft signs in Tunisian patients with schizophrenia. Psychiatry Clin Neurosci. 2010; 64: 645–8.
   Web of Science ®Google Scholar
• Cantor-Graae E, Ismail B, McNeil TF. Are neurological abnormalities in schizophrenic patients and their siblings the result of perinatal trauma?. Acta Psychiatr Scand. 2000; 101: 142–7.
   PubMed Web of Science ®Google Scholar
• Lane A, Colgan K, Moynihan F, Burke T, Waddington JL, Larkin C, etal. Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Res. 1996; 64: 105–14.
   PubMed Web of Science ®Google Scholar
• Ismail B, Cantor-Graae E, McNeil TF. Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings. Schizophr Bull. 2001; 27: 629–41.
   PubMed Web of Science ®Google Scholar
• Mäki P, Veijola J, Jones PB, Murray GK, Koponen H, Tienari P, etal. Predictors of schizophrenia – a review. Br Med Bull. 2005; 73–74: 1–15.
   PubMed Web of Science ®Google Scholar
• Isohanni M, Jones PB, Moilanen K, Rantakallio P, Veijola J, Oja H, etal. Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 Birth Cohort. Schizophr Res. 2001; 52: 1–19.
   PubMed Web of Science ®Google Scholar
• Rosso IM, Bearden CE, Hollister JM, Gasperoni TL, Sanchez LE, Hadley T, etal. Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull. 2000; 26: 367–78.
   PubMed Web of Science ®Google Scholar
• Cannon M, Jones P, Huttunen MO, Tanskanen A, Huttunen T, Rabe-Hesketh S, etal. School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Arch Gen Psychiatry. 1999; 56: 457–63.
   PubMed Web of Science ®Google Scholar
• Schiffman J, Walker E, Ekstrom M, Schulsinger F, Sorensen H, Mednick S. Childhood videotaped social and neuromotor precursors of schizophrenia: a prospective investigation. Am J Psychiatry. 2004; 161: 2021–7.
   PubMed Web of Science ®Google Scholar
• Niemi LT, Suvisaari JM, Tuulio-Henriksson A, Lönnqvist JK. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res. 2003; 60: 239–58.
   PubMed Web of Science ®Google Scholar
• Owens DGC, Johnstone EC. Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context. Psychol Med. 2006; 36: 1501–14.
   PubMed Web of Science ®Google Scholar
• Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, etal. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009; 373: 234–9.
   PubMed Web of Science ®Google Scholar
• Gottesman II. Schizophrenia epigenesis: past, present, and future. Acta Psychiatr Scand Suppl. 1994; 384: 26–33.
   Google Scholar
• Blennow G, McNeil TF. Neurological deviations in newborns at psychiatric high risk. Acta Psychiatr Scand. 1991; 84: 179–84.
   PubMed Web of Science ®Google Scholar
• Fish B. Infant predictors of the longitudinal course of schizophrenic development. Schizophr Bull. 1987; 13: 395–409.
   PubMed Web of Science ®Google Scholar
• Mednick SA, Schulsinger F. Some premorbid characteristics related to breakdown in children with schizophrenic mothers. J Psychiatr Res. 1968; 6(Suppl 1): 267–91.
   Google Scholar
• Marcus J, Hans SL, Auerbach JG, Auerbach AG. Children at risk for schizophrenia: the Jerusalem Infant Development Study. II. Neurobehavioral deficits at school age. Arch Gen Psychiatry. 1993; 50: 797–809.
   PubMed Web of Science ®Google Scholar
• McNeil TF, Kaij L. Swedish high-risk study: sample characteristics at age 6. Schizophr Bull. 1987; 13: 373–81.
   Web of Science ®Google Scholar
• Sameroff AJ, Barocas R, Seifer R. Watt NF, Anthony EJ, Wynne LC, Rolf JE. The early development of children born to mentally ill women. Children at risk for schizophrenia: a longitudinal perspective. 1984; New York: Cambridge University Press. 482–514.
   Google Scholar
• Marcus J, Auerbach J, Wilkinson L, Burack CM. Infants at risk for schizophrenia. The Jerusalem Infant Development Study. Arch Gen Psychiatry. 1981; 38: 703–13.
   PubMed Web of Science ®Google Scholar
• Mirsky AF, Kugelmass S, Ingraham LJ, Frenkel E, Nathan M. Overview and summary: twenty-five-year followup of high-risk children. Schizophr Bull. 1995; 21: 227–39.
   PubMed Web of Science ®Google Scholar
• McNeil TF, Harty B, Blennow G, Cantor-Graae E. Neuromotor deviation in offspring of psychotic mothers: a selective developmental deficiency in two groups of children at heightened psychiatric risk?. J Psychiatr Res. 1993; 27: 39–54.
   PubMed Web of Science ®Google Scholar
• Rieder RO, Nichols PL. Offspring of schizophrenics. III. Hyperactivity and neurological soft signs. Arch Gen Psychiatry. 1979; 36: 665–74.
   PubMedGoogle Scholar
• Marcus J, Hans SL, Lewow E, Wilkinson L, Burack CM. Neurological findings in high-risk children: childhood assessment and 5-year followup. Schizophr Bull. 1985; 11: 85–100.
   PubMed Web of Science ®Google Scholar
• Hans SL, Marcus J, Nuechterlein KH, Asarnow RF, Styr B, Auerbach JG. Neurobehavioral deficits at adolescence in children at risk for schizophrenia: The Jerusalem Infant Development Study. Arch Gen Psychiatry. 1999; 56: 741–8.
   PubMed Web of Science ®Google Scholar
• Isohanni M, Lauronen E, Moilanen K, Isohanni I, Kemppainen L, Koponen H, etal. Predictors of schizophrenia: evidence from the Northern Finland 1966 Birth Cohort and other sources. Br J Psychiatry Suppl. 2005; 48: s4–7.
   Google Scholar
• Walther S, Strik W. Motor symptoms and schizophrenia. Neuropsychobiology. 2012; 66: 77–92.
   PubMed Web of Science ®Google Scholar
• Peralta V, Campos MS, De Jalón EG, Cuesta MJ. Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders. Mov Disord. 2010; 25: 1068–76.
   PubMed Web of Science ®Google Scholar
• Schubert EW, McNeil TF. Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. Am J Psychiatry. 2004; 161: 1030–7.
   PubMed Web of Science ®Google Scholar
• Kinney DK, Yurgelun-Todd DA, Woods BT. Hard neurologic signs and psychopathology in relatives of schizophrenic patients. Psychiatry Res. 1991; 39: 45–53.
   Web of Science ®Google Scholar
• Kinney DK, Woods BT, Yurgelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. II. Neurologic and psychiatric findings in relatives. Arch Gen Psychiatry. 1986; 43: 665–8.
   PubMed Web of Science ®Google Scholar
• Griffiths TD, Sigmundsson T, Takei N, Rowe D, Murray RM. Neurological abnormalities in familial and sporadic schizophrenia. Brain J Neurol. 1998; 121: 191–203.
   Google Scholar
• Ismail BT, Cantor-Graae E, Cardenal S, McNeil TF. Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophr Res. 1998; 30: 229–38.
   PubMed Web of Science ®Google Scholar
• Ismail B, Cantor-Graae E, McNeil TF. Neurological abnormalities in schizophrenic patients and their siblings. Am J Psychiatry. 1998; 155: 84–9.
   PubMed Web of Science ®Google Scholar
• Chen YL, Chen YH, Mak FL. Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. J Nerv Ment Dis. 2000; 188: 84–9.
   Web of Science ®Google Scholar
• Lawrie SM, Byrne M, Miller P, Hodges A, Clafferty RA, Cunningham Owens DG, etal. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry. 2001; 178: 524–30.
   PubMed Web of Science ®Google Scholar
• Yazici AH, Demir B, Yazici KM, Göğüş A. Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophr Res. 2002; 58 : 241–6.
   PubMed Web of Science ®Google Scholar
• Gourion D, Goldberger C, Olie JP, Lôo H, Krebs MO. Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophr Res. 2004; 67: 23–31.
   PubMed Web of Science ®Google Scholar
• Niemi LT, Suvisaari JM, Haukka JK, Lönnqvist JK. Childhood predictors of future psychiatric morbidity in offspring of mothers with psychotic disorder: results from the Helsinki High-Risk Study. Br J Psychiatry. 2005; 186: 108–14.
   PubMed Web of Science ®Google Scholar
• Cantor-Graae E, McNeil TF, Rickler KC, Sjöström K, Rawlings R, Higgins ES, etal. Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma?. Am J Psychiatry. 1994; 151: 1194–9.
   PubMed Web of Science ®Google Scholar
• Niethammer R, Weisbrod M, Schiesser S, Grothe J, Maier S, Peter U, etal. Genetic influence on laterality in schizophrenia? A twin study of neurological soft signs. Am J Psychiatry. 2000; 157: 272–4.
   PubMed Web of Science ®Google Scholar
• Appels MC, Sitskoorn MM, de Boo M, Klumpers UM, Kemps A, Elderson A, etal. Neurological signs in parents of schizophrenic patients. Neuroreport. 2002; 13: 575–9.
   Web of Science ®Google Scholar
• Kelly BD, Cotter D, Denihan C, Larkin D, Murphy P, Kinsella A, etal. Neurological soft signs and dermatoglyphic anomalies in twins with schizophrenia. Eur Psychiatry. 2004; 19: 159–63.
   Web of Science ®Google Scholar
• Solanki RK, Swami MK, Singh P, Gupta S. Identification of vulnerability among first-degree relatives of patients with schizophrenia. East Asian Arch Psychiatry. 2012; 22: 118–25.
   Google Scholar
• Snitz BE, Macdonald AW, Carter CS. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull. 2006; 32: 179–94.
   PubMed Web of Science ®Google Scholar
• Neelam K, Garg D, Marshall M. A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia. BMC Psychiatry. 2011; 11: 139.
   Web of Science ®Google Scholar
• Visscher PM, Hill WG, Wray NR. Heritability in the genomics era – concepts and misconceptions. Nat Rev Genet. 2008; 9: 255–66.
   PubMed Web of Science ®Google Scholar
• Sanders RD, Joo YH, Almasy L, Wood J, Keshavan MS, Pogue-Geile MF, etal. Are neurologic examination abnormalities heritable? A preliminary study. Schizophr Res. 2006; 86: 172–80.
   Web of Science ®Google Scholar
• Hyde TM, Goldberg TE, Egan MF, Lener MC, Weinberger DR. Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls. Br J Psychiatry. 2007; 191: 120–5.
   Web of Science ®Google Scholar
• Chen RY, Sham P, Chen EY, Li T, Cheung EF, Hui TC, etal. No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Res. 2001; 105: 175–85.
   PubMed Web of Science ®Google Scholar
• Özçetin A, Poyraz BÇ, Poyraz CA, Bozhüyük E, Bolat N, Balcioğlu I, etal. T102C polymorphism of serotonin-2A receptor gene in Turkish schizophrenia patients: association with cognitive impairment and soft neurological signs. Indian J Psychiatry. 2014; 56 : 359–64.
   PubMed Web of Science ®Google Scholar
• Galderisi S, Maj M, Kirkpatrick B, Piccardi P, Mucci A, Invernizzi G, etal. Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment. Neuropsychobiology. 2005; 52: 83–9.
   PubMed Web of Science ®Google Scholar
• Lautenschlager NT, Wu JS, Laws SM, Almeida OP, Clarnette RM, Joesbury K, etal. Neurological soft signs are associated with APOE genotype, age and cognitive performance. J Alzheimers Dis. 2005; 7: 325–30.
   Web of Science ®Google Scholar
• Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, etal. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014; 46: 1173–86.
   PubMed Web of Science ®Google Scholar
• Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, etal. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015; 518: 197–206.
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011; 476 : 214–19.
   PubMed Web of Science ®Google Scholar
• Van Den Bossche MJ, Docx L, Morrens M, Cammaerts S, Strazisar M, Bervoets C, etal. Less cognitive and neurological deficits in schizophrenia patients carrying risk variant in ZNF804A. Neuropsychobiology. 2012; 66: 158–66.
   Web of Science ®Google Scholar